Cinacalcet
≥99%
- Product Code: 100094
CAS:
226256-56-0
| Molecular Weight: | 357.41 g./mol | Molecular Formula: | C₂₂H₂₂F₃N |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Cinacalcet is primarily used in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease who are on dialysis. It helps to regulate calcium levels in the blood by controlling the secretion of parathyroid hormone (PTH). This is crucial in preventing complications such as bone disease and cardiovascular issues associated with abnormal calcium and phosphate levels. Additionally, it is also used to manage hypercalcemia in patients with parathyroid carcinoma and in cases of primary hyperparathyroidism where surgery is not an option. By modulating the calcium-sensing receptors in the parathyroid gland, cinacalcet effectively reduces PTH levels, improving patient outcomes.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White To Yellow Solid |
| Purity (%) | 98.5 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | $495.23 |
+
-
|
| 0.050 | 10-20 days | $948.27 |
+
-
|
| 0.250 | 10-20 days | $1,505.78 |
+
-
|
Cinacalcet
Cinacalcet is primarily used in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease who are on dialysis. It helps to regulate calcium levels in the blood by controlling the secretion of parathyroid hormone (PTH). This is crucial in preventing complications such as bone disease and cardiovascular issues associated with abnormal calcium and phosphate levels. Additionally, it is also used to manage hypercalcemia in patients with parathyroid carcinoma and in cases of primary hyperparathyroidism where surgery is not an option. By modulating the calcium-sensing receptors in the parathyroid gland, cinacalcet effectively reduces PTH levels, improving patient outcomes.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :